FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Artificial intelligence won’t take your job—but what are the real concerns around healthcare AI and its use?
AI is an increasingly useful tool in pathology—but its full value can only be realized in collaboration with human experts.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.